complement pathways | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

6,611 results for “complement pathways”

Trials

View all 1665 →

Combined Treatment With Fresh Frozen Plasma and Rituximab (Mabthera) in Patients With Advanced Refractory Chronic Lymphocytic Leukemia

10 participants · First posted May 5, 2009

Endometriosis and Complement System

58 participants · First posted Jul 10, 2024

The Complement Lectin Pathway After Cardiac Arrest

82 participants · First posted Jul 7, 2016

Drugs

View all 98 →

MASP-2 inhibitors (lectin disorders/ Complement pathways disorders)

MASP-2/3 inhibitors (lectin disorders/ Complement pathways disorders)

Novel pathways(Tranquis Therapeutics)

Organizations

View all 12 →

COMPASS Pathways

United Kingdom

SIGNPOSTS (LUTON)

United Kingdom

Dianthus Therapeutics

United States

News

View all 4836 →

Complement-Based Drug Development Gains Momentum Following FDA Approvals and Pipeline Advances

Novartis' FABHALTA Poised to Transform Treatment Landscape for Multiple Complement-Mediated Diseases

ImmunAbs Receives FDA Clearance for Phase 2 Trial of IM-101 Complement Inhibitor in Myasthenia Gravis

Page 1 of 662